Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UNICHEMLAB | NSE
-5.70
-0.86%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
653.40
654.00
667.70
650.05
Unichem Laboratories Limited a pharmaceutical company manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas such as gastroenterology cardiology diabetology psychiatry neurology anti-bacterial anti-infective and pain management; and active pharmaceutical ingredients as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai India.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
49.3%1 month
41.4%3 months
36.5%6 months
36.2%-
-
1.93
0.10
0.08
55.27
2.78
-
1.10B
46.23B
552.54M
-
3.40
-
5.50
-2.94
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
130.50
Range1M
141.15
Range3M
184.50
Rel. volume
0.38
Price X volume
19.26M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Aarti Drugs Limited | AARTIDRUGS | Drug Manufacturers-Specialty & Generic | 525.3 | 48.30B | -0.88% | 28.55 | 44.03% |
Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 86.77 | 47.55B | -2.44% | 40.71 | 3.42% |
Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 380.5 | 46.92B | -4.35% | 72.22 | 68.84% |
Sequent Scientific Limited | SEQUENT | Drug Manufacturers-Specialty & Generic | 177.85 | 44.41B | 0.01% | 774.74 | 74.28% |
Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 399.15 | 40.03B | -0.46% | 46.93 | 62.51% |
Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 143.65 | 36.89B | -1.84% | 14.02 | 0.42% |
RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2174.75 | 36.30B | -2.27% | 43.29 | 0.00% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 370.1 | 34.24B | -1.33% | 46.10 | 60.54% |
Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 155.78 | 33.97B | -0.85% | n/a | 0.26% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 742.9 | 32.02B | -0.01% | n/a | 107.90% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
V2 Retail Limited | V2RETAIL | Apparel Retail | 1148.3 | 39.72B | 0.06% | 133.29 | 191.28% |
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 183.46 | 27.05B | -1.24% | 29.68 | 43.67% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.55 | 27.02B | -4.54% | 82.05 | 10.74% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 229.62 | 23.62B | 0.79% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 55.27 | 23.29 | Expensive |
Ent. to Revenue | 2.78 | 12.02 | Cheaper |
PE Ratio | - | 47.84 | - |
Price to Book | 1.93 | 6.55 | Cheaper |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 36.50 | 40.95 | Par |
Debt to Equity | 0.10 | 0.34 | Cheaper |
Debt to Assets | 0.08 | 0.17 | Cheaper |
Market Cap | 46.23B | 286.13B | Emerging |